Detalles de la búsqueda
1.
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Nat Immunol;
21(11): 1346-1358, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868929
2.
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Nature;
600(7888): 319-323, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819663
3.
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
J Biol Chem;
290(28): 17495-504, 2015 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26023239
4.
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia.
Lung Cancer;
191: 107798, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669727
5.
Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia).
J Thorac Oncol;
18(11): 1538-1549, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543207
6.
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study.
Lung Cancer;
176: 103-111, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634571
7.
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
Cancer Cell;
40(2): 201-218.e9, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090594
8.
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR).
Transl Lung Cancer Res;
10(7): 3059-3070, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430347
9.
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer.
Sci Immunol;
5(43)2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005679
10.
Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer.
Lung Cancer;
99: 1-3, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565905
11.
Impact of single nucleotide polymorphisms on severe hepatotoxicity induced by EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutations.
Lung Cancer;
90(2): 307-13, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26323212
12.
Release profile of insulin entrapped on mesoporous materials by freeze-thaw method.
Int J Pharm;
386(1-2): 172-7, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19931606
Resultados
1 -
12
de 12
1
Próxima >
>>